Monoclonal Antibody for COVID Gets FDA Emergency Use Authorization

The FDA on Tuesday granted emergency use authorization to Inflarx NV's monoclonal antibody for the treatment of hospitalized COVID patients.
Reuters Health Information

source https://www.medscape.com/viewarticle/990441?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors